Below are the most recent publications written about "Receptors, Cytoplasmic and Nuclear" by people in Profiles.
-
Alexander SP, Fabbro D, Kelly E, Mathie A, Peters JA, Veale EL, Armstrong JF, Faccenda E, Harding SD, Pawson AJ, Southan C, Davies JA, Beuve A, Brouckaert P, Bryant C, Burnett JC, Farndale RW, Friebe A, Garthwaite J, Hobbs AJ, Jarvis GE, Kuhn M, MacEwan D, Monie TP, Papapetropoulos A, Potter LR, Schmidt HHHW, Szabo C, Waldman SA. THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Catalytic receptors. Br J Pharmacol. 2021 Oct; 178 Suppl 1:S264-S312.
-
Duker AL, Eldridge G, Braverman NE, Bober MB. Congenital heart defects common in rhizomelic chondrodysplasia punctata. Am J Med Genet A. 2016 Jan; 170A(1):270-2.
-
Hyslop T, Weinberg DS, Schulz S, Barkun A, Waldman SA. Occult tumor burden contributes to racial disparities in stage-specific colorectal cancer outcomes. Cancer. 2012 May 1; 118(9):2532-40.
-
Wang C, Powell M, Tian L, Pestell RG. Analysis of nuclear receptor acetylation. Methods Mol Biol. 2011; 776:169-81.
-
Wang C, Tian L, Popov VM, Pestell RG. Acetylation and nuclear receptor action. J Steroid Biochem Mol Biol. 2011 Feb; 123(3-5):91-100.
-
Lott K, Cingolani G. The importin ß binding domain as a master regulator of nucleocytoplasmic transport. Biochim Biophys Acta. 2011 Sep; 1813(9):1578-92.
-
Bhardwaj A, Cingolani G. Conformational selection in the recognition of the snurportin importin beta binding domain by importin beta. Biochemistry. 2010 Jun 22; 49(24):5042-7.
-
Lott K, Bhardwaj A, Mitrousis G, Pante N, Cingolani G. The importin beta binding domain modulates the avidity of importin beta for the nuclear pore complex. J Biol Chem. 2010 Apr 30; 285(18):13769-80.
-
Dreieicher E, Beck KF, Lazaroski S, Boosen M, Tsalastra-Greul W, Beck M, Fleming I, Schaefer L, Pfeilschifter J. Nitric oxide inhibits glomerular TGF-beta signaling via SMOC-1. J Am Soc Nephrol. 2009 Sep; 20(9):1963-74.
-
Debler EW, Blobel G, Hoelz A. Nuclear transport comes full circle. Nat Struct Mol Biol. 2009 May; 16(5):457-9.